Search

everythinglearnresearchcommunity

for

Search:↓

Immune checkpoint inhibitors can increase the risk of autoimmune skin diseases, especially bullous pemphigoid.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

Doctors should consider SLE in males even if antinuclear antibody tests are negative.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Expanding CD4+ Tregs can stop hair loss in alopecia areata.

Lower MC2R expression may contribute to alopecia areata.

A woman experienced severe symptoms, including hair loss, after a COVID-19 vaccine, suggesting a possible autoimmune reaction.

M-CSF-stimulated myeloid cells can cause alopecia areata in mice.

Higher IL-17A and IL-23 levels are linked to alopecia areata severity and could help in tracking and treating the disease.

Baricitinib is a promising treatment for alopecia areata.

New treatments for alopecia areata may target specific immune cells and pathways involved in hair loss.

Aggressive treatment in young patients with certain drug reactions may lead to multiple autoimmune diseases later.

New genetic discoveries in alopecia areata could lead to better treatments.

Different γδ T cell types have unique roles in causing alopecia areata.

Alopecia areata may involve stress-related changes affecting hormone receptors, leading to reduced cortisol production.

ILC1-like cells can cause alopecia areata by affecting hair follicles.

A young girl had both alopecia areata and immune thrombocytopenic purpura at the same time, suggesting a possible link between the two.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

The study suggests that a specific type of immune cell, memory-like NK cells, may increase during active hair loss in Alopecia areata.

γδ T cells can prevent and treat alopecia areata, offering a new therapy option.

A woman with type 2 diabetes developed alopecia areata, suggesting a link between the two autoimmune conditions.

A man with four autoimmune diseases suggests a new category for multiple autoimmune syndrome.

Atoh1 expression can create new Merkel cells in the skin.

miR-155 levels in blood could help identify alopecia areata.

Anti-TNF therapy can cause a unique type of hair loss that may get better with topical treatments without stopping the therapy.

Treatment with biologic agents can significantly improve psoriasis symptoms, and blood biomarkers could potentially predict individual patient's response to treatment.

Increasing regulatory T cells may help treat alopecia areata by reducing autoimmunity and promoting hair growth.

Unique microRNA patterns can help diagnose and treat severe alopecia areata.

Genetic factors alone might not cause pemphigus vulgaris; other factors like birth complications and puberty may trigger it.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.